ArticleJCO precision oncology2023

Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.

Katherine I Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.